Back

Corrigendum to: Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes

Cardiovascular Research

30 April 2021
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Myeloperoxidase inhibition reverses the inflammatory proteomic pattern in heart failure with preserved ejection fraction
1 July 2021
thumbnail
Congress Presentation
Role of sumoylation modification of sirtuin 3 in hypertension-associated
30 August 2024
thumbnail
Congress Presentation
Cardiac myosin inhibitor, mavacamten, improves myocardial relaxation in mouse HFpEF model
30 April 2022
thumbnail
Congress Presentation
Nitro-oxidative stress impairs single cardiomyocyte adrenergic reserve in a murine model of HFpEF.
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources